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Abstract

The capacity for induced pluripotent stem (iPS) cells to be differentiated into a wide range of neural cell types
makes them an attractive donor source for autologous neural transplantation therapies aimed at brain repair.
Translation to the in vivo setting has been difficult, however, with mixed results in a wide variety of preclinical
models of brain injury and limited information on the basic in vivo properties of neural grafts generated from
human iPS cells. Here we have generated a human iPS cell line constitutively expressing green fluorescent
protein as a basis to identify and characterize grafts resulting from transplantation of neural progenitors into
the adult rat brain. The results show that the grafts contain a mix of neural cell types, at various stages of
differentiation, including neurons that establish extensive patterns of axonal growth and progressively develop
functional properties over the course of 1 year after implantation. These findings form an important basis for
the design and interpretation of preclinical studies using human stem cells for functional circuit reconstruction in animal models of brain injury.
Disciplines

Medicine and Health Sciences
Publication Details

Niclis, J. C., Turner, C., Durnall, J., McDougal, S., Kauhausen, J. A., Leaw, B., Dottori, M., Parish, C. L. &
Thompson, L. H. (2017). Long-distance axonal growth and protracted functional maturation of neurons
derived from human induced pluripotent stem cells after intracerebral transplantation. Stem Cells
Translational Medicine, 6 (6), 1547-1556.
Authors

Jonathan C. Niclis, Christopher Turner, Jennifer Durnall, Stuart McDougal, Jessica A. Kauhausen, Bryan
Leaw, Mirella Dottori, Clare L. Parish, and Lachlan H. Thompson

This journal article is available at Research Online: http://ro.uow.edu.au/ihmri/1178

TISSUE ENGINEERING AND REGENERATIVE MEDICINE
Long-Distance Axonal Growth and Protracted
Functional Maturation of Neurons Derived from
Human Induced Pluripotent Stem Cells After
Intracerebral Transplantation
JONATHAN C. NICLIS,a* CHRISTOPHER TURNER,a* JENNIFER DURNALL,a STUART MCDOUGAL,a
JESSICA A. KAUHAUSEN,a BRYAN LEAW,a MIRELLA DOTTORI,b CLARE L. PARISH,a LACHLAN H. THOMPSONa
Key Words. Grafting • Regeneration • Connectivity • Forebrain • Electrophysiology
a

Florey Institute for
Neuroscience and Mental
Health, Royal Parade,
Parkville, Victoria, Australia;
b
Department of Electrical
and Electronic Engineering,
Centre for Neural
Engineering, University of
Melbourne, Royal Parade,
Parkville, Victoria, Australia
Correspondence: Lachlan
Thompson, PhD, Florey Institute
for Neuroscience and Mental
Health, Royal Parade, Parkville,
Victoria, Australia. Telephone:
61 3 90356796; Fax: 161 3
90353107; e-mail: lachlant@
unimelb.edu.au

*Contributed equally.

Received April 20, 2016; accepted
for publication October 31, 2016;
published Online First on
February 15, 2017.

ABSTRACT
The capacity for induced pluripotent stem (iPS) cells to be differentiated into a wide range of neural cell types makes them an attractive donor source for autologous neural transplantation therapies aimed at brain repair. Translation to the in vivo setting has been difﬁcult, however, with
mixed results in a wide variety of preclinical models of brain injury and limited information on the
basic in vivo properties of neural grafts generated from human iPS cells. Here we have generated a
human iPS cell line constitutively expressing green ﬂuorescent protein as a basis to identify and
characterize grafts resulting from transplantation of neural progenitors into the adult rat brain. The
results show that the grafts contain a mix of neural cell types, at various stages of differentiation,
including neurons that establish extensive patterns of axonal growth and progressively develop
functional properties over the course of 1 year after implantation. These ﬁndings form an important basis for the design and interpretation of preclinical studies using human stem cells for functional circuit re-construction in animal models of brain injury. STEM CELLS TRANSLATIONAL
MEDICINE 2017;6:1547–1556

SIGNIFICANCE STATEMENT
Neurons generated from human pluripotent stem cells can establish extensive patterns of connectivity in a host brain and survive for up to one year after transplantation. Functional maturation, assessed by patch-clamp recordings, occurs over months rather than weeks. These
observations are significant for the design and interpretation of pre-clinical studies aimed at
developing stem cell therapies for brain repair. They demonstrate in principle feasibility for anatomically reconstruction of long-distance circuitry but also highlight that therapeutic impact
linked to functional integration will require sufficient post-transplantation observation times.

INTRODUCTION

c AlphaMed Press
O

1066-5099/2016/$30.00/0
http://dx.doi.org/
10.1002/sctm.16-0198
This is an open access article
under the terms of the Creative Commons AttributionNonCommercial-NoDerivs
License, which permits use
and distribution in any
medium, provided the original
work is properly cited, the use
is non-commercial and no
modiﬁcations or adaptations
are made.

One of the most anticipated clinical applications
for induced pluripotent stem (iPS) cells is the functional replacement of damaged central nervous
system (CNS) circuitry. The capacity of iPS cells to
be differentiated into a wide variety of CNS cell
types has stimulated signiﬁcant research into their
potential as a donor source for a range of neurological conditions characterized by neuronal cell
loss. For example, there are now routine procedures for directed differentiation of human pluripotent cells into midbrain dopamine neurons
relevant for cell-based therapy in Parkinson’s disease (PD) [1], [2], [3] spinal motor neurons for
motor neuron disease or acute spinal injury [4–6],
medium spiny projection neurons for Huntington’s disease [7–10], or cortical projection

neurons [11, 12] that could replace damaged cortical circuitry after stroke or traumatic brain injury.
A key challenge in this ﬁeld is to translate this success at the in vitro level into reliable procedures
for functional cell replacement in models of CNS
damage.
Overall the therapeutic impact in human iPSbased neural transplantation studies has been
highly variable and there has been lack of consensus on the underlying mechanisms (for review see
[13]). For example, in models of PD there have
been reports of modest recovery of simple motor
function [14–16], while in models of stroke and
spinal injury the results have been much more
mixed (for reviews see [17–19]). A general limitation of work in this area has been a lack of
detailed information on the functional and
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anatomical characteristics of neural grafts generated from human
iPS cells. This makes it difﬁcult to link key features of the graft to
the therapeutic impact.
In this study, we demonstrate the utility of a human iPS cell
line constitutively expressing green ﬂuorescent protein (GFP) as a
tool for characterizing anatomical and functional features of neural grafts derived from iPS cells. Stable expression of GFP in all differentiated cell types up to 1 year after intracerebral
transplantation into adult, athymic rats allowed us to chart the
progressive development of electrophysiological properties of
grafted neurons and to provide a detailed description of the anatomical patterns of long-distance axonal growth in the host brain.
These results are consistent with recent studies using human
embryonic stem (ES) cells [12, 20, 21] and highlight the protracted
nature of functional maturation of neurons generated from
human iPS cells as well as their remarkable capacity for longdistance axonal growth throughout the adult brain.

MATERIALS AND METHODS
Cell Culture and Differentiation
iPS cells (iPS1, WiCell USA) were cultured as previously described
[22] at 378C, 5% CO2 on mitomycin-C treated human foreskin
ﬁbroblasts in media consisting of DMEM/nutrient mixture F-12,
supplemented with 0.1 mM b-mercaptoethanol, 1% nonessential
amino acids, 2 mM glutamine, 25 U/ml penicillin, 25 lg/ml streptomycin and 20% knockout serum replacement, KSR (all from Invitrogen). The iPS-GFP cells were generated using the piggyBac
transposon vector (Wellcome Trust Sanger Institute) modiﬁed to
contain a GFP expression cassette, driven by the human elongation factor 1 alpha promoter. For neural induction, colonies were
treated with human recombinant noggin (500 ng/ml, PeproTech)
and basic Fibroblast Growth Factor, (bFGF, 4 ng/ml, R&D Systems)
in neural basal media (NBM) [23]. After 11 days, colonies were
mechanically harvested and cultured in suspension in NBM supplemented with 20 ng/ml bFGF and 20 ng/ml epidermal growth
factor (EGF, R&D Systems) as neurospheres for a further 7 days,
then dissociated into a single cell suspension using triple express
medium (Invitrogen) and re-suspended at 1 3 105 cells per microliter in HBSS without Ca21 or Mg21, supplemented with 0.05%
DNase.

Animals and Transplantation
The use of animals in this study conformed to the Australian
National Health and Medical Research Council’s published Code of
Practice for the Use of Animals in Research, and experiments
were approved by the Florey Institute for Neuroscience and Mental Health Animal Ethics Committee. A total of 20 female athymic
rats were used as transplant recipients, with 4 animals allocated
to each of the three time-points for electrophysiological studies
and the remaining 8 allocated for histological analysis at the study
end point (50 weeks). Under deep anesthesia (2% isoﬂurane) each
rat was placed in a stereotaxic frame (Kopf, Germany) and
received an injection of 1 3 105 cells (differentiated for 18 days)
in a volume of 1 ml using a glass cannula ﬁtted to a 5 ml Hamilton
syringe as previously described [24]. The cells were injected into
the striatum (0.5 mm anterior and 2.5 mm lateral to Bregma,
4 mm below the dura) over 1 minute and the cannula left in place
a further 2 minutes to minimize reﬂux. The animals were maintained on a normal 12 hours light/dark cycle in individually

ventilated cages and low irritant bedding with ad libitum access to
food and water for the remainder of the experiment.

Electrophysiology
Cortical Slice Preparation. Coronal forebrain slices were prepared from grafted rats 10, 26, and 50 weeks following implantation. Rats were deeply anesthetized with an overdose of
isoﬂurane (100 mg/kg) and the brains were rapidly removed and
cooled. Sections (200 mm) were collected at the level of the graft
site using a vibrating microtome (VT1000S; Leica Microsystems
Inc., Bannockburn, IL) and placed in artiﬁcial cerebrospinal ﬂuid
(aCSF) containing (mM): 125 NaCl, 3 KCl, 1.2 KH2PO4, 1.2 MgSO4,
25 NaHCO3, 10 dextrose and 2 CaCl2 (300 mOsmol). At 308C,
bubbled with 95% O225% CO2. For recordings slices were secured
with a nylon mesh and perfused with aCSF at 328C–348C, bubbled
with 95% O2 and 5% CO2.
Whole Cell Electrophysiology. Recording pipettes (3.2–4.5
MX) were guided to iPS cells identiﬁed by GFP in the striatum or
overlying cortex. Neurons were visualized using Dodt gradient
contrast (x40 water immersion lens) and ﬁlter set 38 on an Axio
Examiner ﬁxed stage microscope (Zeiss, Thornwood, NJ) with digital camera (Rolera EM-C2, Q imaging, Surrey, BC). Pipettes were
ﬁlled with a low Cl- intracellular solution containing (mM): 6 NaCl,
4 NaOH, 130 K-gluconate, 11 EGTA, 1 CaCl2, 1 MgCl2, 10 HEPES, 2
Na2ATP, and 0.2 Na2GTP Na2GTP and 0.5% biocytin (pH 7.3 and
296 mOsm). As a consequence, ECl 5 269mV, inhibitory postsynaptic currents (IPSCs) had small amplitudes at VH 5 260mV,
though more prominent outward current amplitudes were
achieved by shifting to VH 5 240mV in some cases. All recordings
were made in open, whole cell patch conﬁguration under voltage
clamp using a Multiclamp 700B (Molecular Devices, Sunnyvale,
CA). Signals were sampled at 20 kHz and ﬁltered at 10 kHz using
p-Clamp software (version 10.3, Molecular Devices, Sunnyvale,
CA). After recordings, slices were ﬁxed in 4% PFA and incubated
for 2 hours with streptavidin-555 (ThermoFisher) diluted 1:500 in
PBS. Voltage clamp measurements. Cells were held at 260 mV
and inward spontaneous excitatory postsynaptic currents (EPSCs)
were recorded for 3 minutes. Cells were held at 240 mV and outward spontaneous IPSCs were recorded for 3 minutes.
Membrane Potential Measurements. Action potentials (APs)
were stimulated in current-clamp mode. Resting membrane
potential was recorded over 1 minute. Membrane potential
adjusted to 260 mV (current subtraction 26 6 2 pA for all cells)
and cells depolarized with a series of 400–1000 ms current pulses
in 20 pA increments up to 260 pA.
Data Analysis and Statistics. For input-ouput curves, APs were
counted over the step period and groups compared by two-way
ANOVA with Student-Newman-Keuls post hoc. Proportions of iPS
cells that exhibited AP failures in response to a 260 pA step were
compared by z test. Spontaneous EPSC frequency and amplitudes
were compared by one-way ANOVA with Dunn’s post hoc. Proportions of iPS cells that exhibited spontaneous excitatory postsynaptic currents (sEPSCs) were compared by z test.

Immunohistochemistry
Fifty weeks after transplantation, animals received a lethal dose
of pentobarbitone and were trans-cardially perfused with 50 ml
saline (0.9% wt/vol) followed by 200–250 ml paraformaldehyde
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Figure 1. Neural induction of human induced pluripotent stem cells constitutively expressing GFP. (A): Phase contrast image showing colony
formation with typical neuroepithelial morphology after 5 days of neural induction. (Bi–Biv): Colonies at 11 days express regional markers
PAX6 and OTX2 consistent with a dorsal forebrain progenitor phenotype. (C): At the time of transplantation (day 18), native GFP can be readily visualized in live neurospheres generated from the center of neuroepithelial colonies. (Di–Dv): Cryosectioned spheres show uniform cytoplasmic expression of GFP and widespread expression of neural progenitor markers including Sox2 and Vimentin. (Ei–Ev): Many of the Sox21
neural progenitors also expressed the dorsal marker Pax7 at the time of transplantation. Scale bars: A, C–1 mm; B, 500 mm; D, E 400 mm.
Abbreviation: GFP, green ﬂuorescent protein.

(PFA; 4% wt/vol in 0.1 M phostphate buffered saline (PBS)). The
brains were removed, postﬁxed a further 2 hours in PFA and cryoprotected in sucrose (25% wt/vol in 0.1 M PBS). Brains were sectioned in the coronal or horizontal plane in 12 series at a thickness
of 30 lm on a freezing microtome (Leica, Germany). Immunohistochemistry on free-ﬂoating sections was as previously described
[25]. Primary antibodies and dilution factors were as follows: goat
anti-doublecortin (DCX, 1:400; SCBT), rabbit anti-GABA (1:2,500;
Sigma), rabbit anti-GFAP (1:200; DAKO), chicken anti-GFP (1:1,000;
AbCam), rabbit anti-GFP (1:20,000; AbCam), rabbit anti-Ki67
(1:1,000; ThermoFischer), mouse anti-NeuN (1:1,000; Millipore),
rabbit anti-Otx2 (1:500; Millipore), mouse anti-Pax7 (1:80; DSHB),
mouse anti-Pax6 (1:100; DSHB), goat ant-Sox2 (1:100; R&D Systems), rabbit anti-TBR1 (1:100; Millipore), mouse anti-VGLUT2
(1:500; Millipore), rabbit anti-Vimentin (1:500; Abcam) . For DABbased detection of GFP, a biotinylated goat anti-rabbit secondary
anti- body (Vector Laboratories) was subsequently conjugated
with streptavidin-HRP using the Vectastain ABC Elite kit (Vector
Laboratories). For immunoﬂuorescence detection, species-speciﬁc
secondary antibodies generated in donkey and conjugated with
the Dylight range of ﬂuorophores with various peak emission
wavelengths including 488, 549, and 633 were used at a dilution
of 1:500 (Jackson ImmunoResearch).

Imaging and Histological Quantification
Fluorescent images were captured using a Zeiss Meta laser scanning confocal upright microscope. To provide macroscopic illustrations of GFP immunoreactivity, montages of single darkﬁeld
images captured using a 320 objective were constructed using a
Leica DM6000 B upright light microscope equipped with a motorized stage. The sections and GFP1 ﬁber patterns were reconstructed by tracing over the montaged images using Canvas

www.StemCellsTM.com

software (ACD systems). Morphological proﬁles of biocytin ﬁlled
cells were generated by accurately tracing over collapsed z-stacks
of the streptavidin-555 labeled dendrites using Adobe photoshop
software.
Graft volumes were estimated through extrapolation of the
area of GFP measured in every 12th section according to Cavalieri’s principle [26]. The cellular densities of the grafts were
estimated through counting of DAPI-labeled nuclei in three
separate 340 (225mm2) ﬁelds of view for each graft in ﬁve animals. The proportion of NeuN and TBr1 expressing neurons in
three of the grafts was estimated by inspection of every DAPI
cell in three separate 320 (425mm2) ﬁelds of view in each of
three grafts.

RESULTS
Rapid Neural Induction and Acquisition of Regional
Identity of Human iPS Cells Stably Expressing GFP
Upon neural induction, human iPS cells formed colonies with characteristic neuroepithelial morphology by d5 (Fig. 1A) that were
then treated with FGF2 to promote the expansion of neural progenitors. This resulted in colonies enriched for early telencephalic
transcription factors, including the forebrain/midbrain regional
marker OTX2 and dorsal forebrain marker PAX6 (Fig. 1B). These
colonies were manually dissected to generate neurospheres that
robustly express GFP at the time of transplantation (Fig. 1C).
Immuno-labeling of cryosectioned neurospheres ﬁxed at the time
of transplantation showed cytoplasmic distribution of GFP ubiquitously throughout the spheres as well as proteins indicative of an
early neural progenitor phenotype, including SOX2 and Vimentin
(Fig. 1D) and Pax7 (Fig. 1E) consistent with dorsal regional
identity.
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Figure 2. Neurons derived from human induced pluripotent stem (iPS) cells progressively develop functional properties over the course of
1 year after implantation into the adult rat brain. (A): iPS derived cells were identiﬁed by GFP expression and targeted for whole cell recordings (pipette from right, scale 5 20 lm). Pipettes contained biocytin to ﬁll neurons. (B): Representative examples of biocytin ﬁlled neurons at
10, 26, and 50 weeks show the progressive development of more complex morphological features, including some with pyramidal proﬁles by
50 weeks (scale 100 lm). (C): APs ﬁring became increasingly frequent and reliable the longer iPS cells remained in vivo. Representative traces
from neurons at each time point show the depolarization response to 0, 40, and 260 pA steps. (D): Input/output curves show the greater
capacity to sustain increasing currents at the later in vivo time-points (n 5 6 at 10 weeks, n 5 5 at 26 weeks, n 5 14 at 50 weeks). Pie-charts
show the proportion of cells with sustainable APs at 260 pA (*, p < .05 vs. 10 week, #, p < .05 vs. 26 week, two way ANOVA). Abbreviations:
AP, Action potentials; GFP, green ﬂuorescent protein; pA, amplitude.

Progressive Electrophysiological Maturation of iPS CellDerived Neurons In Vivo
For electrophysiological assessment of grafted neurons, coronal
slices were prepared 10, 26, and 50 weeks after transplantation.
Native GFP ﬂuorescence allowed for rapid identiﬁcation of grafted
cells, which were patched for whole cell recordings under dodt
contrast in all slices (Fig. 2A). Representative reconstructed images
of biocytin ﬁlled cells at 10, 26, and 50 weeks after transplantation
showed a progressive maturation of neuronal morphology, most
notably though the more prominent dendritic branching and
spine density at 50 weeks (Fig. 2B). All recorded cells exhibited
neuron-like resting membrane potentials (10 weeks, 256 6 2 mV,
n 5 6; 26 weeks, 269 6 3 mV, n 5 5; 50 weeks, 267 6 2 mV,
n 5 14). At the early 10-week postgraft time-point half of the cells
failed to generate an APs response to current injections (Fig. 2C,
2D). We did, however, observe 3 out of 6 cells that were able to
generate low amplitude APs that collapsed at higher (60 pA) current injections (Fig. 2D). At 26 weeks, recordings in 5 cells produced APs that were notably more robust in terms of amplitude
and ﬁred at higher frequencies with current injections although
an overall heterogeneous input/output response was noted, with
3 cells sustaining regular AP ﬁring up to 260 pA while 2 exhibited
a collapsing pattern similar to the cells recorded at 10 weeks
(Fig. 2C, 2D). At 50 weeks, observations in 14 GFP1 cells showed

that the main distinction relative to the earlier time-points was
the consistency of the input/output response with 13 of 14 cells
able to sustain regular high amplitude AP ﬁring with increasing
frequency in response to current steps up to 260 pA (Fig. 2C, 2D).
This suggests by 50 weeks, post implantation, the majority of iPS
cells expressed a sufﬁcient voltage activated ion channel density
to support this high intensity output.
To assess if iPS cell derived neurons receive functional afferent input, voltage clamp recordings were also performed in the
same neurons at each post-transplantation time-point. At 10
weeks, there was no evidence of sEPSCs in any of the 6 cells (Fig.
3A, 3B). At 26 weeks, 2 of 5 cells exhibited sEPSCs at low frequency (0.03 6 0.02 Hz) but with high amplitude (48 6 6 pA). By
50 weeks post-transplantation, sEPSCs were observed in all 14
GFP1 cells and these occurred at greater frequency (1.4 6 0.3
Hz) compared to earlier time points but were not different in
amplitude to sEPSCs at 26 weeks (Fig. 3B). In one of these 50
week cells, we also observed inhibitory postsynaptic currents (0.7
Hz, 20 pA–not shown).

Long-Term Survival and Extensive Axonal Growth from
Neural Grafts Derived from Human iPS Cells
Histological analysis 50 weeks after transplantation showed that
expression of GFP was maintained uniformly throughout the
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Figure 3. Neurons derived from human induced pluripotent stem cells exhibit properties of synaptic integration in vivo. (A): Representative
traces from neurons in voltage clamp at each time point demonstrating sEPSCs at 26 and 50 weeks. (B): Accompanying graphs show the frequency (Hz) and amplitude (pA) of sEPSCs in recorded cells at each time-point, as well as the proportion of cells exhibiting sEPSCs (*, p < .05
vs. 10 week, #, p < .05 vs. 26 week, one way ANOVA or z test). Abbreviations: EPSCs, excitatory postsynaptic currents; sEPSCs, spontaneous
excitatory postsynaptic currents.

grafted iPS cells. Grafts were present as discrete deposits in the
dorsal head of the striatum as well as the overlying corpus callosum and frontal cortex. In some animals, reﬂux of the cells along
the injection tract meant that the graft deposit was contained
entirely within the cortex, rather than the striatal target site (e.g.,
Fig. 4A). The graft volumes were highly variable (8.86 6 4.84 mm3)
and thus so were the total number or DAPI1 cells (2.19 6 1.24 x
106), representing on average an approximate 20-fold increase
from the original donor preparation of 1 3 105 cells per animal.
Even at the 50-week time-point there was a persistence of immature neural cell types, including small clusters of doublecortin1/
GFP1 cells with neuroblast morphology that had migrated a short
distance into the adjacent host cortex (Fig. 4B) and dividing
Ki671/Sox21 progenitors within the graft core (Fig. 4C). There
were also examples of individual GFP1 cells with more mature
morphological proﬁles consistent with terminally differentiated
neurons and glia that had migrated from the graft into the adjacent host parenchyma (Fig. 4D).
Labeling for glial ﬁbrillary acidic protein (GFAP) revealed some
examples of GFAP1/GFP1 cells (Fig. 4E), however the ﬁlamentous nature of GFAP labeling made it difﬁcult to estimate the proportion of these cells within the grafts. Double-labeling with
NeuN showed a substantial number of GFP1 cells with mature
neuronal identity (Fig. 4F). These cells were distributed in a nonuniform manner throughout the grafts, with dense clusters of
NeuN1 cells interspersed with areas sparsely populated with
NeuN1 cells. Counting of NeuN1 cells by sampling from multiple
ﬁelds of view within each graft revealed that 17.45% 6 2.2% of
grafted (DAPI1/GFP1) cells were NeuN1 neurons. Labeling with
other phenotypic markers indicated that some of these neurons
had a dorsal forebrain identity, with 17.45% 6 2.2% of GFP1/
NeuN1 cells coexpressing Tbr1 (Fig. 4F). We also observed as
well as heterogeneously distributed pockets of cells densely
labeled for Otx2 and/or Pax7 (Fig. 4G), however these were
largely not NeuN1, possibly representing the persistence of dorsal forebrain and midbrain progenitor cells in the mature grafts.
In terms of neurochemical phenotype of the grafted neurons,
we did not observe any evidence of neurons with dopaminergic
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(TH), cholinergic (ChAT) or serotonergic (5HT) identity (not shown).
We did, however, observe numerous GABA1/GFP1 neurons and
dendrites throughout the grafts (Fig. 4H) as well as a dense pattern
of punctate labeling for the vesicular glutamate transporter
VGLUT2 (Fig. 4I, 4J). Although within the graft core it was not possible to unambiguously associate the VGLUT21 with grafted cells
(as opposed to innervating host ﬁbers), close inspection of individual GFP1 ﬁbers coursing through white matter tracts showed at
least some of the grafted neurons colabeled for VGLUT2 (Fig. 4J).
One of the most striking aspects of the histological analysis
was the capacity for grafted neurons to establish extensive patterns of long-distance axonal growth throughout the host brain. A
conspicuous feature was the propensity for axonal growth along
host white matter tracts of the external and internal capsules.
Large numbers of GFP1 axons extended medio-laterally, across
both hemispheres, via the corpus callosum and anterior commissure (Fig. 5A, 5J) and also throughout the rostro-caudal axis via
the external capsule and myelinated ﬁber bundles of the internal
capsule (Fig. 5A–5C). In the rostral direction, ﬁbers extended
through forceps minor and could be found as far as the olfactory
bulb (Fig. 5D). Growth caudal to the graft was extensive, travelling
long distances along the internal capsule, ventrally through the
entopeduncular nucleus (Fig. 5A, 5F) and cerebral peduncles (Fig.
5A, 5G) and into the brainstem (Fig. 5A). Dorsally, GFP1 ﬁbers
coursed along the superior cerebellar peduncle and into the arbor
vitae of the cerebellum (Fig. 5A, 5E).
Innervation of speciﬁc host nuclei was most prominent proximal to white matter corridors, particularly in cortical areas including those adjacent to the ventral extremities of the external
capsule (Fig. 5A, 5H) and overlying the corpus callosum and forceps minor (Fig. 5A, 5I). Fibers also exited the corpus callosum
ventrally into the septum (Fig. 5A 5J). Few ﬁbers were observed
to innervate thalamic nuclei, although there was a prominent passaging of ﬁbers medial from the entopeduncular nucleus toward
the hypothalamus (Fig. 5M). Immediately adjacent to the graft in
the striatum, high magniﬁcation images showed dense ﬁber networks with a punctate pattern consistent with terminal ramiﬁcation (Fig. 5A, 5K, 5L).
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Figure 4. Composition of neural grafts generated from human induced pluripotent stem cells 50 weeks after transplantation. (A): Immunohistochemistry for GFP in a coronal section shows an example of a graft contained within the host cortex and corpus callosum. (B): Cells with
the morphology of migrating neuroblasts could be found in the adjacent host parenchyma (Bi) and many of these cells colabeled with doublecortin (Bii). (C): Other immature neural cell types persisted in the grafts at 50 weeks including Sox21 progenitors, some of which were
actively dividing based on Ki67 expression (boxed area shown as separate color channels). (D): Many of the cells also had more differentiated
morphology, some with neuronal proﬁles (Di–Diii) while others with glial morphology were often found in close proximity to host blood vessels (Div; arrow). (E): Labeling for GFAP showed a strong ﬁlamentous pattern of GFAP1 throughout the grafts including a number GFAP1/
GFP1 cell bodies. (F): NeuN and Tbr1-expressing GFP1 cells could be found throughout the grafts, although the distribution was nonuniform—this image shows one of the regions with a high frequency of these cells (boxed area shown as separate color channels). (G): Other
transcription factors associated with dorsal forebrain identity, including Otx2 and Pax7 were also found in restricted areas as discrete clusters
in the grafts (boxed area shown as separate color channels). (H): In terms of neurochemical identity, GABA1/GFP1 cells could be found
throughout the grafts and VGLUT2 immunoreactivity (I) was also prevalent with a punctate pattern of labeling throughout all grafts (note the
cell nuclei as dark areas lacking cytoplasmic GFP for scale reference). (J): Analysis of individual GFP1 ﬁbers (here in the corpus callosum)
showed colocalization of VGLUT2 (boxed area enlarged as separate color channels). Scale bars: A–1 mm; Bi, Div, E, F, G, H, J–50 mm; Bii, Di–
Diii, I–20 mm. Abbreviation: GFP, green ﬂuorescent protein.
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Figure 5. Long-distance ﬁber growth of grafted neurons throughout the host brain. (A): Reconstructions of darkﬁeld photo-montages of coronal
(A-i–A-iv, top row) and horizontal (A-v, A-vi, bottom) sections labeled for GFP 50 weeks after transplantation. The GFP1 ﬁbers were carefully traced
over by hand. The graft appears as a black deposit in the corpus callosum (section ii) or the striatum and overlying cortex (sections A-v, A-vi). Approximate location of the section planes are shown in the sagittal section (top right). Brightﬁeld images of DAB-labeled immunohistochemistry for GFP
from the same sections (boxed) used for the reconstructions show GFP1 ﬁbers: coursing through host white matter tracts including the external capsule (B) and internal capsule (C); extending into the olfactory bulb (D); in the arbor vitae of the cerebellum (E); extending caudally through the entopeduncular nucleus (F) and cerebral peduncles (G); innervating cortical areas adjacent to the external capsule, including the perirhinal cortex (H) and
frontal cortical areas rostral to forceps minor (I); coursing between hemispheres though the corpus callosum and ventrally into the septum around
the midline (J); innervating the striatum (K) with a punctate pattern of terminal ramiﬁcation (L); and running medially from the internal capsule
toward the hypothalamus (M). Abbreviations: 3v, third ventricle; Av, arbor vitae; cc, corpus callosum; ctx, cortex; ec, external capsule; ic, internal capsule; lv, lateral ventricle; OB, olfactory bulb; PRh, perirhinal cortex. Scale bars: A–1mm (both); B, C, E, I–200 mm; D, F, G, H, J, K, M–100 mm; L–50 mm.
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DISCUSSION
These results demonstrate that neurons generated from human
iPS cells can survive up to 1 year after transplantation into the
fully developed brain, where they develop functional electrophysiological properties and can form widespread patterns of longdistance axonal growth. The total number of cells in the grafts represented an increase ranging between 4- to 30-fold compared
to the original 1 x 105 cells grafted, demonstrating signiﬁcant proliferation and net growth subsequent to transplantation. Indeed,
even at 50-weeks there was a persistence of actively dividing
Ki671/Sox21 neural progenitors.
The cytoplasmic distribution of GFP showed distinct neuronal
morphologies, some with pyramidal appearance, while there
were also clusters of bipolar neuroblasts around the periphery of
the graft, suggesting on-going neurogenesis even up to 1 year
after grafting. This extends on previous studies using human ES
cells, showing the persistence of neural progenitors 3 months
after grafting [20, 27]. Clusters of Otx2 and Pax7 expressing cells
suggest the persistence of progenitors with dorsal mid/forebrain
identity. The grafts also displayed properties that suggested at
least some of the neurons may have acquired a cortical projection
phenotype, including dendritic VGLUT21 expression and large
numbers of Tbr1 expressing cells. This would be consistent with
previous reports showing a “default” differentiation of human pluripotent stem cells toward dorsal forebrain cell types under minimalist neural induction conditions [20, 28, 29].
A signiﬁcant feature of the in vivo properties of the grafts was
the remarkable growth of GFP1 ﬁbers over long distances in the
adult brain. This follows ﬁndings from similar studies using human
ES cells, showing grafts of dorsal forebrain progenitors implanted
into the frontal cortex of Non-Obese Diabetic/severe combined
immune deﬁciency (NOD/SCID) mice establish extensive patterns
of axonal growth, including innervation of midbrain and hindbrain
targets [12, 27] and grafts of ventral midbrain progenitors
implanted into the midbrain of athymic rats establish long-distance
patterns of axonal connectivity with striatal and cortical forebrain
targets [21]—for review see [13]. Here we report that neurons generated from iPS cells share this capacity for long-distance axonal
growth in the fully developed brain. One of the most conspicuous
features of the GFP1 growth pattern was the tendency for axonal
extension along host white matter corridors. This included projections into the contralateral cortex, via the corpus callosum, as well
as extensive growth caudally along the internal capsule and into
the brainstem. These patterns are similar to those reported following grafting of human ES cell-derived dorsal forebrain progenitors
into the neonatal [20] or adult [12, 27] rodent forebrain.
This may simply reﬂect a permissive growth trajectory given
the close proximity of the grafts to major white matter structures
including the corpus callosum. It is difﬁcult to conﬁdently distinguish between such passive growth properties and cell-intrinsic
patterns of target-directed growth. Retrograde tracing studies by
Espuny-Camacho et al. [12] support the idea that at least some
component may represent cell-intrinsic growth preference by
showing that grafted neurons corresponding to different cortical
layers maintained distinct growth trajectories appropriate to their
normal developmental targets. As we have discussed previously
[13], the overall pattern of growth will likely reﬂect both targetdirected outgrowth but also growth of unspeciﬁed progenitors
that may take their cues from the host environment. Furthermore,
any component of directed growth likely reﬂects the presence of

various neuronal subtypes. Here we found that, using a procedure
for rapid neural induction and relying on “default” acquisition of
regional identity, the resulting grafts were of mixed composition,
with only a minor proportion of cells that could be deﬁned on the
basis of molecular markers of phenotype, including Tbr11/
NeuN1 neurons that may represent dorsal forebrain (cortical projection) neurons. Thus, the innervation of known cortical projection targets including the contralateral cortex, striatum, and
brainstem may reﬂect the presence of cortical projection neurons.
Lack of innervation of other major cortical projection targets, such
as thalamus, may suggest the absence of the corresponding cortical subtypes under these differentiation conditions. Further studies, including retrograde tracing approaches, will be of great
beneﬁt as a means to further characterize the origins of innervation of speciﬁc host nuclei according to neuronal phenotype.
At a functional level, transplanted neurons were able to
acquire mature electrophysiological properties including sustained
ﬁring of APs in response to increasing current steps as well as evidence of afferent synaptic input. Both the intrinsic ﬁring properties and also the capacity to support afferent input, based on
frequency of sEPSCs under voltage clamp, showed a markedly protracted time-course of development over 1 year. The maturation
state of the cells was clearly distinguishable at the 10, 26, and 50week time-points. This is consistent with transplantation studies
using human ES cells, where ex vivo recordings show an immature
phenotype at 6–12 weeks but more complex ﬁring patterns from
18 weeks onward [12, 20, 30]. In the study by Espuny-Camacho
et al. [12], ES derived cortical neurons continued to mature up to
9 months in terms of both their electrophysiological properties
and also at the anatomical level based on increased innervation of
the host brain and development of dendritic complexity. Similarly,
Steinbeck et al. [27] reported a progressive maturation of human
ES cell grafts between 12 and 48 weeks in terms of the relative
contribution of mature (NeuN) and immature (Ki671, Nestin1)
cell types. More recently, Avaliani et al. [31] showed that neurons
generated from human iPS cells have immature intrinsic electrophysiological proﬁles and do not accommodate functional afferent
input from the host after 6 weeks of coculture on mouse organotypic hippocampal slices. However, when grafted into athymic rats
and examined at 24 weeks, path clamped human neurons display
more mature membrane resistance and ﬁring properties and
receive functional input from the host. Taken together with the
present results, it suggests that the functional maturation was not
determined by differences in the mouse organotypic and rat transplantation models but rather is a general feature of neurons generated from human pluripotent stem cells.
While the capacity of these cells to acquire intrinsic functional
properties in vivo is encouraging for cell replacement strategies
for brain repair, a remaining challenge is the convincing demonstration that their projection pathways can functionally innervate
speciﬁc host nuclei. At the ultrastructural levels at least, the
human ES grafting studies by Steinbeck et al. [27] made use of
human-speciﬁc synaptophysin antibodies to provide convincing
demonstration of synaptic coupling of grafted human neurons
with rodent host neurons. The development of technology to
selectively stimulate or inhibit grafted neurons, for example, via
optogenetics or manipulation through DREADDs, should further
aid in the assessment of functional connectivity. These approaches
have already been used to study the integration of human ES cell
derived neurons in rodent models, including inhibitory
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interneurons grafted into the hippocampus [32] and midbrain
dopamine neurons grafted into the striatum (Steinbeck et al.
2015).

CONCLUSION
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In summary, these results show that neural grafts generated from
human iPS cells survive up to 1 year - a clinically relevant timeframe for cell replacement based therapies in patients - develop
mature functional properties and establish extensive patterns of
long-distance axonal growth throughout the host brain. These
observations form an important basis for further studies aimed at
understanding the relationship between the in vivo properties of
grafted neurons and therapeutic outcome following transplantation in models of CNS injury. In particular, detailed information on
anatomical integration properties through the use of reporter
lines, and using human speciﬁc antibodies to polysialylated
nuclear cell adhesion molecule. as recently demonstrated by[21],
will allow for a more conclusive insight into the importance of
innervation of speciﬁc host nuclei than has previously been shown
in transplantation studies using human pluripotent cells[13]. Overall, the in vivo properties of neurons generated from human iPS
cells appear similar to those already reported in similar studies
using ES cells[12, 20, 27], including a protracted maturation period
over months. This has important implications for the design and
interpretation of pre-clinical studies aimed at cell replacement in
animal models of brain injury. It suggests that rapid therapeutic
impact after transplantation, as has been reported in models of
stroke and trauma [33–40], is likely due to mechanisms not
related to functional cell replacement such as neuroprotection or
stimulation of host plasticity. Demonstration of therapeutic impact
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